ACD PHARMACEUTICALS AS: årsregnskap 2002 vs 2001
Grew 492% on revenue, stronger earnings, cash halved-plus
Summary
What changed
Comparing Årsregnskap 2002 with 2001 for ACD PHARMACEUTICALS AS. Revenue 217.0k NOK → 1.28m NOK (+491.9%). Net result +5 119 NOK → +379.5k NOK. Equity 204.8k NOK → 382.7k NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: cash fell.
Net constructive year on the published lines.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 217.0k NOK to 1.28m NOK (+491.9% YoY). Calculated
-
↑
Operating result improved
Operating result +223.4k NOK → +553.3k NOK (op. margin 102.9% → 43.1%). Calculated
-
↑
Net result improved
Net result +5 119 NOK → +379.5k NOK (net margin 2.4% → 29.5%). Calculated
-
↑
Equity strengthened
Book equity 204.8k NOK → 382.7k NOK (equity ratio 33.9% → 143.4%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 133.6k NOK → 12 NOK (-100.0% YoY). Calculated